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Abstract
Background: Cells are able to communicate and coordinate their function within tissues via secreted factors.
Aberrant secretion by cancer cells can modulate this intercellular communication, in particular in highly organised
tissues such as the liver. Hepatocytes, the major cell type of the liver, secrete Dickkopf (Dkk), which inhibits
Wnt/β-catenin signalling in an autocrine and paracrine manner. Consequently, Dkk modulates the expression of
Wnt/β-catenin target genes. We present a mathematical model that describes the autocrine and paracrine regulation
of hepatic gene expression by Dkk under wild-type conditions as well as in the presence of mutant cells.
Results: Our spatial model describes the competition of Dkk and Wnt at receptor level, intra-cellular Wnt/β-catenin
signalling, and the regulation of target gene expression for 21 individual hepatocytes. Autocrine and paracrine
regulation is mediated through a feedback mechanism via Dkk and Dkk diffusion along the porto-central axis. Along
this axis an APC concentration gradient is modelled as experimentally detected in liver. Simulations of mutant cells
demonstrate that already a single mutant cell increases overall Dkk concentration. The influence of the mutant cell on
gene expression of surrounding wild-type hepatocytes is limited in magnitude and restricted to hepatocytes in close
proximity. To explore the underlying molecular mechanisms, we perform a comprehensive analysis of the model
parameters such as diffusion coefficient, mutation strength and feedback strength.
Conclusions: Our simulations show that Dkk concentration is elevated in the presence of a mutant cell. However, the
impact of these elevated Dkk levels on wild-type hepatocytes is confined in space and magnitude. The combination
of inter- and intracellular processes, such as Dkk feedback, diffusion and Wnt/β-catenin signal transduction, allow
wild-type hepatocytes to largely maintain their gene expression.
Keywords: Wnt/β-catenin signalling pathway, Dickkopf diffusion and feedback regulation, APC concentration
gradient, Mathematical model, Paracrine and autocrine regulation, Reaction-diffusion system
Background
Cells are exposed to numerous external factors, arriving
from environmental sources as well as surrounding cells.
Factors secreted by cells into the extracellular space can
be used for intercellular communication and by that for
the coordination of cellular functions on the cell popula-
tion or tissue level. Cancer cells also secrete factors but
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the composition and amount can differ compared to that
of wild-type cells. Thereby, cancer cells can alter their
microenvironment and exert a different impact on sur-
rounding cells than wild-type cells. In consequence, gene
expression and cellular functions of the surrounding cells
can change. The effects are of critical importance in tis-
sues with a complex spatial specialisation of cells, as e.g. in
the liver. Here, we investigate howDickkopf (Dkk), a factor
secreted by normal andmutated hepatocytes and acting in
an autocrine as well as paracrine manner, influences gene
expression in the hepatic cellular environment.
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
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The liver is the largest gland of the mammalian body
with a multitude of functions including blood detoxifica-
tion, protein synthesis, regulation of glucose metabolism,
and production of hormones and bile. It has long been
known that hepatocytes, the predominant cell type of
the liver, accomplish distinct biochemical tasks dependent
on their location along the periportal (PP) - pericentral
(PC) axis of the sinusoids of liver lobules (Fig. 1a) [1–7].
For example, glycolysis and glutamine synthesis occur
predominantly in the PC region, while gluconeogenesis
and urea formation occur predominantly in the PP region
[2, 3, 5, 7, 8]. This physiological phenomenon is referred
to as functional zonation and is paralleled by distinct gene
expression programmes [1–7]. The underlying mecha-
nisms causing functional zonation are intensively stud-
ied. According to current hypotheses extracellular factors,
such as oxygen, hormones, or morphogens, are differently
abundant along the porto-central axis and control the par-
ticular gene expression of hepatocytes located in specific
zones of the liver sinusoids [7, 8].
Experimental findings indicate that intracellular com-
ponents of the Wnt/β-catenin signalling pathway, in par-
ticular β-catenin and adenomatous polyposis coli (APC),
are also important contributors to functional zonation
[9–12]. Immunostaining in liver sections showed that
the total intracellular APC concentration decreases from
a
b
Fig. 1 Simplified scheme of liver architecture and Wnt/β-catenin signalling. a: The human liver is composed of two lobes of unequal size. It is
supplied with blood from two sources, the hepatic portal vein and the hepatic arteries. The blood is distributed into capillaries that enter the liver
lobules, which are hexagonal substructures that form the functional units of the liver. The blood flows through the sinusoids of the lobules from the
portal vein (PV) to the central vein (CV). Hepatocytes surround the sinusoids separated by space of Disse. Typically, 15 to 25 hepatocytes align along
the porto-central axis. b: The central component of the Wnt/β-catenin signalling pathway is β-catenin (purple). β-Catenin is constantly produced
and degraded and maintains a low expression level. The degradation is predominantly mediated by a destruction complex comprising APC (grey),
Axin and the kinase GSK. Upon stimulation by Wnt ligands (grey), the Wnt receptor complex activates intracellular proteins including Dishevelled
(Dsh) that induce a partial inactivation of the destruction complex. In consequence, β-catenin degradation is impaired and more β-catenin can
translocate into the nucleus. There, it binds to transcriptional regulators of the TCF family and co-regulates the expression of target genes. In
particular, β-catenin/TCF complexes induce the expression of Dkk (green). Dkk is secreted by the cells and acts as an inhibitor of the pathway by
competing with Wnt for receptor binding. The colours highlighting Wnt, APC, β-catenin, target genes and Dkk correspond to the colour code used
throughout the manuscript
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one hepatocyte to the next along the porto-central axis,
i.e. a gradient of APC exists along the sinusoid [10].
This gradient is paralleled by differential expression
of Wnt/β-catenin target genes associated with ammo-
nium metabolism such as glutamine synthetase [10].
Other immunohistochemical experiments revealed that
loss of β-catenin or loss of Wnt co-receptor low-density-
lipoprotein receptor-related proteins 5 and 6 (LRP) impair
zonation emphasising the involvement of Wnt/β-catenin
signalling in its proper formation [9, 11, 12].
The central component of the Wnt/β-catenin sig-
nalling pathway is the transcriptional regulator β-catenin
(Fig. 1b). β-Catenin associates with transcription fac-
tors of the T-cell factor/lymphoid enhancer factor (TCF)
family in the nucleus to regulate the expression of spe-
cific target genes [13–15]. The abundance of β-catenin
is controlled by a multi-protein complex, referred to as
destruction complex, in which APC, Axin, and glycogen
synthase kinase 3 (GSK3) are central components. Bound
to APC and Axin in this destruction complex, β-catenin
becomes phosphorylated by GSK3 resulting in the pro-
teasomal degradation of β-catenin [16–18]. This process
maintains low concentrations of β-catenin in the cell and
thus prevents the activation of Wnt/β-catenin-dependent
target genes.
Extracellular stimulation of a cell with the morphogen
Wnt directs the transmembrane receptor Frizzled (Frz)
and co-receptor LRP into close proximity establishing the
Wnt/Frz/LRP complex [19, 20]. This formation of a recep-
tor complex allows signal transduction to downstream
proteins in the cell resulting in the partial inhibition of the
destruction complex [19, 21]. The exact molecular mech-
anism has yet to be resolved but Dishevelled (Dsh) seems
to play a central role [19, 21, 22]. The partial inhibition
of the destruction complex impairs β-catenin degrada-
tion [23, 24]. In consequence, more β-catenin can enter
the nucleus, associate with TCF transcription factors, and
regulate target gene expression [13–15].
Various extracellular proteins are known to modulate
Wnt/β-catenin signal transduction on the receptor level
such as secreted frizzled-related proteins or Dkk proteins
[25–27]. In vertebrates, the Dkk protein family comprises
fourmembers (Dkk1, Dkk2, Dkk3 andDkk4) that have dif-
ferent biochemical and physiological properties [25, 27].
In our study, Dkk1 is exclusively considered (hereafter
referred to as Dkk). Secreted Dkk binds extracellularly
to LRP and thereby interferes with the formation of the
Wnt/Frz/LRP complex [28–30]. By that mechanism, Dkk
can affect downstream signalling events and hence target
gene expression. Dkk expression is induced by Wnt/β-
catenin signalling establishing an autocrine feedback loop
[31, 32]. In addition, secreted Dkk has been proposed
to diffuse and influence adjacent cells in a paracrine
manner [33, 34].
In hepatocellular carcinoma (HCC), a prominent type of
liver cancer, Dkk is overexpressed [35, 36]. The secreted
protein can readily be monitored in the blood and is
therefore discussed as potential biomarker for the diag-
nostics of HCC cells in clinical research [35, 37, 38]. HCC
cells frequently harbour mutations in β-catenin (19-33%)
[39–42], Axin (5-15%) [40, 41, 43] or APC (2%) [41]. These
mutations can alter the destruction complex-dependent
degradation of β-catenin resulting in β-catenin accumu-
lation even in the absence of an external Wnt stimulus.
Nuclear accumulation of β-catenin has been detected in
HCC samples [38, 42, 44] and may be the underlying
reason for Dkk overexpression.
In the present study, we use a mathematical mod-
elling approach to investigate the autocrine and paracrine
effects of Dkk on the mRNA expression of target
genes that are regulated by Wnt/β-catenin signalling in
the liver. Previously, various mathematical models have
been published [45–47] investigating different aspects
of the Wnt/β-catenin signalling pathway, such as recep-
tor activation [48–50], regulation of signal transduction
[49, 51–57], feedback mechanisms [58–60], interplay of
β-catenin with E-cadherin [55, 61] or the control of hep-
atic target gene expression [54, 62, 63]. Modelling efforts
addressed spatial aspects within tissues especially in the
crypts of the colon [64–67]. Also the impact of diffu-
sion of pathway activators and inhibitors and/or crosstalk
with other signalling pathways has been investigated
[34, 68–75]. Our reaction-diffusion model combines
many of these diverse aspects by integrating Dkk-
regulated events at the Wnt receptor level with signal
transduction processes and gene regulation in the context
of a hepatic APC concentration gradient. It is considered
that Dkk exerts an autocrine influence because produced
and secreted Dkk can act back on the LRP receptor of
the secreting cell itself. Furthermore, Dkk mediates a
paracrine regulation: secreted Dkk diffuses and binds the
LRP receptor of adjacent cells. Our investigation is set in
a liver-specific context in which a concentration gradient
of APC along the porto-central axis exists.
In addition, we explore how a single mutant cell may
affect gene expression in adjacent wild-type hepatocytes.
We simulate this single mutant cell by a reduction of
the destruction-complex-dependent degradation of β-
catenin. This reduction reflects the aberrant regulation
caused by APC, Axin or β-catenin mutations that have
been associated with HCC [39–43]. The analysis of the
model without a mutant cell reveals that Dkk feedback
and diffusion have opposite effects on target gene expres-
sion along the porto-central axis. We demonstrate that
already a single mutant cell considerably increases over-
all Dkk concentration compared to the wild-type scenario.
This mutant cell-derived Dkk can diffuse along the porto-
central axis, affect signalling in adjacent wild-type cells,
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and reduce their target gene mRNA expression. However,
the elevated Dkk levels have a limited impact on gene
expression of wild-type hepatocytes, which, moreover, is
confined to the immediate vicinity of the mutant cell.
Methods
The spatial model of Dkk-regulated Wnt signalling con-
sists of a set of ordinary differential equations (ODEs)
for each cell. Cells were coupled by a reaction-diffusion
equation describing the evolution of Dkk, which was dis-
cretised by finite differences, yielding a set of ODEs. The
equations are provided in Additional file 1 (Section A).
Calculations were done with Matlab R2016b (The Math-
Works, Natick, MA). Steady state solutions were numer-
ically obtained (stiff ODE solver). The Matlab code is
available in Additional file 2.
Results
Spatial model of hepatic Wnt signalling considering Dkk
feedback and diffusion
Structure and components of themodel
We aim to investigate the impact of Dkk on target gene
expression in the context of an APC gradient in the
liver. We focus our modelling approach on the 15-25
hepatocytes that typically align along the porto-central
axis parallel to a liver sinusoid (Fig. 1a) [6]. Our model
considers 21 cells that each harbour the identical struc-
ture of the Wnt/β-catenin signalling pathway including
the regulatory Dkk feedback (Fig. 2) but differ in their
total concentration of APC to simulate an APC gradient
increasing from PC to PP [10]. Each cell produces Dkk
that can influence the Wnt/β-catenin pathway of its pro-
ducing cell (autocrine feedback) or can diffuse along the
portal-central axis and impact the signalling of other cells
(paracrine regulation). In our modelling approach, Dkk is
the only component that diffuses.
To describe the Wnt/β-catenin signalling pathway,
we employ the signal transduction module of a pub-
lished model [54]. This signalling module focusses on
the intracellular interactions of the central signal media-
tor β-catenin (Fig. 2b, reactions 1-9). β-Catenin is pro-
duced (reaction 1) and degraded in an APC-independent
(reaction 2) and APC-dependentmanner (reaction 3). The
APC-dependent reaction represents the degradation of β-
catenin that is mediated by the destruction complex. This
reaction can be inhibited by activated Dsh (Dsha). Dsha
is produced from inactive Dsh (Dshi) in a Wnt/Frz/LRP
receptor complex-dependent way (reaction 8) and may
reconvert into Dshi again (reaction 9). β-Catenin can
reversibly form a complex with APC (reaction 4). This
complex represents the binding of β-catenin to APC inde-
pendent of the destruction complex [51]. In case of high
concentrations of β-catenin, this complex formation acts
as a positive feedback by reducing the concentration of the
destruction complex [76]. β-Catenin can also reversibly
form a complex with the transcription factor TCF
(reaction 5). In the model, the resulting β-catenin/TCF
complex is considered to be the transcriptional activa-
tor of gene expression. TCF is produced (reaction 6)
and degraded (reaction 7). The pathway components
Dsh and APC obey conservation relations; that is, their
respective total concentrations remain constant over time
(Additional file 1, Section A).
We extend this signalling module by a module of tar-
get gene expression (Fig. 2b, reactions 10-13 and 17-18).
In this module, the β-catenin/TCF complex activates
the transcription of an unspecified target gene mRNA
(reaction 17), which we consider as the readout in our
model analyses. This unspecified target gene mRNA is
degraded (reaction 18) but not translated for the sake
of simplicity of the model. In addition to the unspeci-
fied target gene mRNA, we include the transcriptional
activation of Dkk mRNA by the β-catenin/TCF complex
(reaction 10). Dkk mRNA is degraded (reactions 11) or
translated into Dkk. We do not explicitly consider intra-
cellular Dkk in our model. Rather the two processes of
intracellular translation of Dkk mRNA and secretion of
Dkk into extracellular space are lumped into one process
(reaction 12), which produces extracellular Dkk. The loss
of extracellular Dkk (reaction 13) can similarly be under-
stood as a lumped process combining clearance of Dkk
from extracellular space and its intracellular degradation.
The model furthermore integrates a previously pub-
lished receptor module [49], which describes the molecu-
lar mechanisms of extracellular Dkk and Wnt binding to
the membrane-boundWnt receptor subunits LRP and Frz
(Fig. 2b). Wnt binds sequentially and reversibly to Frz and
LRP, which results in the formation of the Wnt/Frz/LRP
complex (reactions 14 and 15, respectively). This com-
plex mediates the activation of Dshi and therefore acti-
vates the downstream signalling pathway. The formation
of the Wnt/Frz/LRP complex can be inhibited by Dkk.
Dkk sequesters unbound LRP into Dkk/LRP complexes
(reaction 16), that do not mediate Dshi activation. The
total concentrations of LRP and Frz are conserved in our
model.
The model focusses on spatial effects along the porto-
central axis, which is discretised into 21 segments of
equal size representing the 21 hepatocytes being typically
located along the axis [6]. In the model, Dkk can diffuse
and therefore it can act on LRP of the Dkk producing
cell as well as on LRP of neighbouring cells (Fig. 2). Dkk
secreted by hepatocytes is presumed to diffuse in extra-
cellular space (space of Disse) to neighbouring cells rather
than being transported by blood flow. Consequently, a
convection term of Dkk is not considered here. In our
model, only 1-D diffusion along the porto-central axis is
considered. Wnt is also an extracellular component but
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Fig. 2 Schematic representation of the mathematical model. a: The spatial model considers a single row of 21 adjacent hepatocytes. Each
hepatocyte harbours the identical structure of the Wnt/β-catenin signalling pathway shown in (b), but differs in its total APC concentration. Dkk
may diffuse along the row of cells through the space of Disse as indicated by the green arrows. b:Model scheme exemplarily shown for
neighbouring hepatocytes. The hepatocytes and their nuclei are indicated by light and dark brown backgrounds, respectively. The reaction scheme
is identical in each of the 21 cells. The model is subdivided into three modules: the receptor module, the signalling module, and the target gene
module. Components in a complex are separated by slashes. One-headed arrows denote reactions taking place in the indicated direction;
double-headed arrows illustrate reversible binding reactions. Dashed arrows represent activation mechanisms; the dashed line ending in T-shape
denotes inhibition. The number next to an arrow specifies the number of the reaction. Model equations and the reference parameter set are
provided in the Additional file 1 (Section A). Note that Dkk can diffuse (green arrow) to all neighbouring hepatocytes on the right and left side
in contrast to Dkk, a Wnt diffusion is not considered
in the model. To our knowledge, there exists no exper-
imental evidence showing diffusion of Wnt in the liver.
In the following paragraphs, we will investigate the con-
sequences of different hypothesised concentration gradi-
ents of Wnt. These different concentration gradients are
explicitly defined by setting total Wnt for each of the 21
cells to a particular value.
Model parameters are collected from several experimen-
tal [77–80] and theoretical publications [49, 51, 54, 60].
Synthesis processes that are not regulated are described
by constant rates; all other reactions follow mass-
action kinetics. The inhibitory impact of Dsha on APC-
dependent β-catenin degradation is implemented as an
inhibitory function as commonly used in mathematical
models of signal transduction pathways [81]. The cho-
sen kinetics represent the simplest possible descriptions
of reactions for which the detailed mechanistics of the
individual steps are missing and which are widely used in
models of signal transduction pathways [81–84]. Details
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on the model parameters and model equations are pro-
vided in the Additional file 1 (Section A). We analyse the
system in steady-state. Uniqueness of the steady-state is
shown in the Additional file 1 (Section B).
Effect of the autocrine and paracrine regulation by Dkk on
the target genemRNA expression in hepatocytes
Autocrine and paracrine regulations are introduced in
the model via Dkk feedback and Dkk diffusion. To study
their effects we analyse the target gene mRNA expres-
sion in cells along the porto-central axis. Histochemical
experiments in liver sections revealed that hepatic target
gene expression is associated with an APC concentration
gradient that increases from PC to PP region [10]. More-
over, while Wnt ligands have to be present [9, 10], to
our knowledge no experimental evidence for gradient in
these ligands exists. We therefore start our model analy-
sis assuming an APC gradient that increases 5-fold from
20 nM (PC) to 100 nM (PP) and equal total Wnt concen-
tration of 1 nM acting upon the individual hepatocytes
(Fig. 3a). The choice of the maximal APC concentration
is motivated by concentrations of the model of Lee et al.
[51], which is the basis of our signallingmodule (seemodel
description in [54]). Since previous analyses have revealed
that APC concentrations higher than 100 nM have only a
minor impact on the downstream target gene expression
[54], only cases of lower APC concentrations are consid-
ered. APC concentrations lower than 100 nM have also
been measured experimentally in mammalian cells [85].
The total Wnt concentration is fixed for each cell to 1 nM
since this concentration is described to induce a strong
impact on mRNA levels in the model [54].
To investigate the influence of the signalling processes
on target gene mRNA expression, we first consider only
reactions 1-9 of the signalling module and reactions 17-
18 of the target gene module (Fig. 2b). In this setting
the model species Wnt and Wnt/Frz are not explic-
itly included. In consequence, the concentration of the
Wnt/Frz/LRP complex equals total Wnt (Additional file
1, Eq. 22). Simulations show that the APC gradient is
almost completely mapped on the target gene mRNA
expression profile, although with an opposite orientation,
with an expression 4.5 times higher in the PC region
than in the PP region (Fig. 3bA, c). Next, we addition-
ally take processes 14 and 15 of the receptor module
into account and thus explicitly include the model species
Wnt and Wnt/Frz complex. The respective simulations
reveal hardly any change in target gene mRNA expression
(Fig. 3bB) compared to the absence of Wnt-receptor regu-
lation (Fig. 3bA). Hence, the target genemRNA expression
is hardly affected by the addition of the Wnt receptor
module.
In the next step, we investigate the impact of the
autocrine effect of Dkk. We therefore include the Dkk
feedback by taking additionally reactions 10-13 and 16
into account. To cover different possible conditions, we
consider a weak or a strong feedback (Fig. 3bC, bD,
respectively). The inclusion of the Dkk feedback reduces
both the absolute target gene mRNA expression in each
cell as well as the relative PC/PP expression ratio (Fig. 3c).
This is caused by Dkk competing with Wnt for LRP bind-
ing, which reducesWnt-induced signalling and thus target
gene mRNA expression. Since the expression of Dkk per
cell depends on the APC concentration, the impact of the
Dkk feedback on target gene expression depends on the
cell’s location within the APC gradient along the porto-
central axis. The stronger the Dkk feedback, the more
prominent the reduction of the target genemRNA expres-
sion. In the case of the strong feedback (Fig. 3bD), absolute
target gene mRNA expression is reduced by 71% PC
(cell 1) and 59% PP (cell 21) compared to the combina-
tion of signalling and target gene module (Fig. 3bA). The
PC/PP ratio of target gene mRNA expression is reduced
from 4.5 to 3.2 (Fig. 3c).
Finally, we also include the diffusion of Dkk in the extra-
cellular space and therefore enable paracrine regulation.
The assumption of a weak diffusion rate (Fig. 3bE) results
in a moderate change compared to the simulations with-
out Dkk diffusion (Fig. 3bD) and yields a PC/PP expres-
sion ratio of 3.8 (Fig. 3c). In contrast, higher PC/PP
expression ratios are obtained by fast Dkk diffusion
(Fig. 3bF). In both cases the absolute target gene expres-
sion is reduced compared to the cases without Dkk
regulation (Fig. 3bA, bB).
Taken together, we observe that the autocrine regula-
tion by Dkk leads to a reduction in the target gene mRNA
expression. This is accompanied by a reduction in the rel-
ative PC/PP expression levels in a liver sinusoid. These
effects caused by the Dkk feedback are partly counter-
acted if in addition Dkk diffusion is considered. In the
following we use a diffusion rate of 10μm2s and a Dkk
translation rate (i.e., feedback strength) of 0.02 min−1
as reference parameters (Fig. 3bE; Additional file 1:
Table S1). This value of the diffusion coefficient
corresponds to diffusion of an average protein in cyto-
plasm [79].
Impact of gradient shapes on target genemRNA expression
So far we analysed our model for a specific APC gradi-
ent along the porto-central axis and an equal Wnt level
for all hepatocytes. While the existence of an APC gradi-
ent is well-established [10], the exact shape has not been
reported so far. Direct spatially resolved measurements
of hepatic Wnt are still missing but Wnt ligands have to
be present for proper hepatic zonation [10]. Additional
experiments have shown that Wnt2 and Wnt9b are pro-
duced in a more pronounced manner by endothelial cells
located at the central vein than by endothelial cells located


















Fig. 3 Effect of selected model processes on target gene mRNA expression along the porto-central axis. a: A constant total Wnt concentration for
each cell (1 nM) and an exponential gradient of total APC concentration increasing 5-fold from PC (20 nM) to PP (100 nM) is assumed. b: The target
gene mRNA expression profiles are shown for different model setups: A: The expression profile is shown if only the signalling module is considered
(Wnt/Frz/LRP complex concentration is set to 1 nM, reaction rates k10 to k16 are set to 0; this setup is equivalent to the published signalling model
[54]). This model setup is successively extended by consideration of B: the receptor module without Dkk feedback and diffusion, C: the receptor
module with a weak Dkk feedback (k12 = 2 · 10−3 min−1) and no diffusion, D: the receptor module with a stronger Dkk feedback (k12 = 2 · 10−2
min−1) and no diffusion, E: the receptor module with a stronger Dkk feedback k12 = 2 · 10−2 min−1) and weak diffusion (D =10 μm2s ), F: the
receptor module with a stronger Dkk feedback k12 = 2 · 10−2 min−1) and stronger diffusion (D =500 μm2s ). c: The PC/PP target gene mRNA
expression ratios for the model setups presented in (b) are compared
along the sinusoid [86]. This opens the possibility for
higher Wnt concentrations in the PC than in the PP
region. Experiments related to somitogenesis and wing
development and in the intestine crypt, suggest that
Wnt gradients exist in these biological contexts [87–92].
Hence, it is at least possible that a gradient of Wnt exists
in the liver, too.
In the following, we explore to what extent the tar-
get gene mRNA expression profile is affected by different
combinations of potential distributions of APC and Wnt
along the porto-central axis. We start with the situation
analysed in Fig. 3a, that is, an exponential gradient of total
APC concentration increasing 5-fold from PC (20 nM) to
PP (100 nM) and constant total Wnt concentration for
each cell (1 nM) (Fig. 4a).We compare this setting with the
conditions of constant total APC concentration (100 nM)
in each hepatocyte and a totalWnt concentration gradient
that exponentially increases by 5-fold from PC (1 nM)
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Fig. 4 Different combinations of Wnt and APC gradients yield qualitatively different target gene mRNA expression profiles. Shown are the
concentrations of total Wnt (upper row) and total APC (middle row) as well as the resulting target gene mRNA concentrations (lower row) along the
porto-central axis. a: Constant total Wnt (1 nM) and a gradient of total APC increasing exponentially from PC (20 nM) to PP (100 nM). This represents
the reference parameter set; further details are given in the Additional file 1 (Section A). b: Constant total APC (100 nM) and a gradient of total Wnt
increasing exponentially from PC (1 nM) to PP (5 nM). c: Gradients of total Wnt and total APC increasing exponentially from PC (1 nM and 20 nM,
respectively) to PP (5 nM and 100 nM, respectively). Both total Wnt and total APC concentrations change five-fold along the porto-central axis. d:
Gradients of total Wnt and total APC, increasing exponentially from PC (0.1 nM and 50 nM, respectively) to PP (5 nM and 100 nM, respectively). Total
Wnt concentration changes 25 times stronger than that of total APC along the porto-central axis. e: A gradient of total Wnt decreasing
exponentially from PC (5 nM) to PP (1 nM) in combination with a gradient of total APC increasing exponentially from PC (20 nM) to PP (100 nM)
to PP (5 nM) (Fig. 4b). The simulations show that the
resulting target gene mRNA expression profiles of the
two conditions differ in their orientations and PC/PP
ratios. The target gene mRNA expression decreases with
increasing APC concentration (Fig. 4a) but increases with
increasing Wnt concentration (Fig. 4b). While the 5-fold
increase in total APC concentration from PC to PP leads
to a 3.8-fold decrease in the target gene mRNA expres-
sion, the 5-fold increase in Wnt along the PC-PP axis
results in a 1.6-fold increase in the target gene mRNA
expression. Applying both a Wnt and an APC concentra-
tion gradient that exponentially increase 5-fold from PC
to PP leads to a profile of target gene mRNA expression
that decreases from PC to PP (Fig. 4c). This is the same
direction as observed in the case of constant Wnt concen-
tration combined with the identical APC concentration
gradient (Fig. 4a). However, the PC/PP ratio of target gene
mRNA expression is decreased to 2.4 (Fig. 4c) compared
to 3.8 (Fig. 4a). The underlying reason is that the highWnt
concentration in the PP region counteracts the negative
effect of high APC concentration on β-catenin concen-
tration resulting in higher target gene mRNA expression
in the PP region. By increasing the Wnt concentration
gradient further to 50-fold from PC to PP and reducing
the APC concentration gradient to 2-fold, the target gene
mRNA expression profile changes its orientation (Fig. 4d)
in the same direction as observed for the combination of
constant total APC concentration and an exponential total
Wnt concentration gradient (Fig. 4b). Such a dependence
of the direction of the target gene mRNA expression pro-
file on the steepness of the considered gradients does not
occur if Wnt and APC concentration gradients are ori-
ented in opposite directions (Fig. 4e). In that case, the
target gene mRNA expression profile always opposes the
direction of the APC gradient independent of parametri-
sation and steepness of the assumed gradients (Additional
file 1, Section B.2).
In summary, our simulations reveal that the APC gra-
dient strongly affects the spatial profile of target gene
mRNA expression. Additional gradients in Wnt might
contribute to the particular shape of the profile. An oppo-
site orientation ofWnt and APC gradients (Fig. 4e) always
results in target gene mRNA expression profiles that have
opposite orientation with respect to the applied APC
concentration gradient. In contrast, APC and Wnt con-
centration gradients oriented in the same direction along
the porto-central axis can give rise to target gene mRNA
expression profiles in the same as well as opposite direc-
tion of the applied APC concentration gradient depending
on the respective steepness of the APC and Wnt concen-
tration gradients (Fig. 4c, d). However, this latter scenario
is less likely since experiments indicate rather a higher
Wnt concentration in the PC region [86]. Hence, the sce-
narios presented in Fig. 4b-d are not very likely in a healthy
liver and are not further investigated in the present study.
Moreover, the setting with equal APC concentration in
all cells (Fig. 4b) seems highly unlikely in a healthy liver,
but might occur under abnormal circumstances, which
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affect APC turnover or the formation and maintenance of
the APC gradient.
Both the scenarios in Fig. 4a and in Fig. 4e are bio-
logically reasonable and do not contradict experimental
findings regarding the presence of APC and Wnt. Less
assumptions on Wnt are required in the scenario with
equal Wnt concentration for each hepatocyte. Therefore,
in the following analyses, we focus on the scenario pre-
sented in Figs. 4a and 3 presuming an APC gradient
increasing 5-fold from 20 nM (PC) to 100 nM (PP) in com-
bination with a constant total Wnt concentration of 1 nM
acting on each cell.
Impact of a single mutant cell on target gene mRNA
expression
Comparison of wild-type andmutant scenario
Aberrant activation of the Wnt/β-catenin pathway is fre-
quently observed in human cancer such as HCC [93–96].
In HCCs, mutations in β-catenin, Axin or APC have been
detected that interfere with the degradation of β-catenin
by the destruction complex [39–43]. Here we explore to
what extent a mutation in a single hepatocyte can impair
signal transduction in the surrounding wild-type cells. In
the model, the mutation is implemented by decreasing the
APC-dependent degradation rate of β-catenin (Fig. 2b,
reaction 3). This mutation is present in a single cell along
the porto-central axis (referred to as mutant cell) while
for all other cells the wild-type condition is considered.
We compare the target gene mRNA expression of such
a mutant scenario with that of the wild-type scenario, in
which wild-type conditions are considered for all 21 cells.
We start our investigation assuming that the mutant cell is
positioned in the centre of the porto-central axis (cell 11).
The mutation is realised by a 10-fold decrease in the APC-
dependent β-catenin degradation rate (k3) compared to
that in a wild-type cell. The simulations show that the tar-
get gene mRNA expression of the mutant cell is strongly
increased compared to that of cell 11 in the wild-type
scenario (Fig. 5a, c). This increased expression results
from the decreased APC-dependent β-catenin degrada-
tion under mutant condition. In addition to the increased
target gene mRNA expression, the mutant cell also pro-
duces more Dkk compared to cell 11 in the wild-type
scenario. Due to diffusion, Dkk is distributed along the
porto-central axis resulting in increased Dkk levels for
all cells in the mutant scenario compared to wild type
scenario (Fig. 5b, d, f). In the considered case, Dkk is







Fig. 5 Impact of a mutant cell on target gene mRNA expression and Dkk concentration. a, b: Target gene mRNA expression (a) and Dkk
concentration (b) profiles in the wild-type scenario. c, d: Target gene mRNA expression (c) and Dkk concentration (d) profiles in the presence of a
cell harbouring a mutation that impedes APC-dependent β-catenin degradation. In the model the mutation is realised by a ten-fold decrease in the
APC-dependent β-catenin degradation rate (k3) in the cell positioned at the centre of the porto-central axis (cell 11). e: Relative change of target
gene mRNA expression of the mutant scenario (c) compared to the wild-type scenario (a), i.e.
[target gene mRNA]mutant scenario−[target gene mRNA]wild-type scenario
[target gene mRNA]wild-type scenario
,
stated in %. f: The average concentration of Dkk per cell is compared between wild-type (b) and mutant (d) conditions. The reference parameter set
(Additional file 1: Table S1) is considered in the simulations
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counteracts the pathway activation induced by Wnt, the
target gene mRNA expression of the surrounding wild-
type cells is decreased in the mutant scenario compared
to wild-type scenario (Fig. 5e). The decrease of the target
gene mRNA expression is strongest in the cells directly
adjacent to the mutant cell (cells 10 and 12) and becomes
less with increasing distance from themutant cell (Fig. 5c).
The effect is slightly asymmetric; the relative change is
slightlymore pronounced in cell 12 than in cell 10 (Fig. 5e).
The reason is that cells towards PC already produce more
Dkk than cells towards PP due to their lower APC concen-
trations.
Taken together, the incorporation of a mutation leads
to a strong up-regulation of target gene mRNA expres-
sion in the mutant cell. The mutant cell also produces
more Dkk than any wild-type cell along the porto-
central axis. By means of Dkk diffusion, the mutant cell
impacts neighbouring cells in a paracrine manner, which
leads to a reduction of their target gene expression. The
absolute changes of target gene mRNA expression in
the surrounding cells are less pronounced than that in
the mutant cell itself. The strongest paracrine effect of the
mutant cell, i.e., the most pronounced relative change of
target gene mRNA expression in the surrounding cells,
occurs in the immediate neighbour towards the PP region.
We will therefore use the immediate neighbour towards
the PP region as so-called readout cell in the following
analyses.
Effect of mutant cell’s position on target genemRNA
expression
First, we tested whether these results depend on the
position of the mutant cell in the APC gradient. To
this end, we studied the impact of the position of
the mutant cell within the gradient on the target gene
mRNA expression of the readout cell. We find that the
effect on the neighbouring cell is only slightly depen-
dent on the mutant’s location within the gradient (Fig. 6).
Target gene expression in the readout cell is reduced
between 12% (if the mutant cell occurs in the centre of
the gradient) and 16% (if the mutation occurs in cell 2 or
20). The slightly stronger effect in the cases of mutant cell
positions 2 or 20 compared to position 11 is due to the
boundary condition of our diffusion model.
Effect of mutation strength on target genemRNA expression
One might also ask how strongly the results depend
on the assumed mutation strength. To simulate
increasing mutation strength, the APC-dependent β-
catenin degradation rate constant k3 of the mutant cell
is reduced. The smaller this rate constant, the more Dkk
is produced by the mutant cell (Fig. 7c) and the stronger
is the impact on the target gene mRNA expression in
the readout cell (Fig. 7a). In the extreme case of no
Fig. 6 Effect of the mutant cell’s position on target gene mRNA
expression. The position of the mutant cell along the porto-central
axis is varied and the impact on target gene mRNA expression of the
readout cell is plotted
APC-dependent β-catenin degradation (k3 = 0) there is
a limit in the impact on target gene mRNA expression.
The reason is that in this extreme case, the β-catenin
concentration is fixed to the ratio of its synthesis rate and
APC-independent degradation rate constant (reactions 1
and 2, respectively). Consequently, the Dkk concentration
that can be produced by a mutant cell is limited by this
maximal possible β-catenin concentration (Fig. 7b, c).
Effect of diffusion on target genemRNA expression
To investigate the impact of the Dkk diffusion coefficient
on the relative change in target gene mRNA expression of
the readout cell, the diffusion coefficient is varied between





, hardly any difference in tar-
get genemRNA expression betweenwild-type andmutant
scenario is observed because diffusion is too weak for Dkk
produced by the mutant cell to reach neighbouring cells
(Fig. 8a). The larger the diffusion coefficient becomes, the
stronger is the impact on target gene mRNA expression in
the readout cell until the strongest impact is observed at
a diffusion coefficient of about 0.6μm2s . Further increase
in the diffusion coefficient leads to a smaller impact on
the target gene mRNA expression in the direct neigh-
bourhood but an increase of the impact on more distant
cells (Fig. 8). In the case of large diffusion coefficients(
> 102 μm2s
)
, the impact on the direct neighbourhood as
well as more distant cells becomes very similar.
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a b c
Fig. 7 Effect of mutation strength on target gene mRNA expression and Dkk concentration. a: The impact on target gene mRNA expression of the
readout cell is computed for different APC-dependent β-catenin degradation rates (k3). A decrease in the APC-dependent β-catenin degradation
rate represents an increase in mutation strength (indicated by the grey inlet). b: β-Catenin steady state concentrations in the mutant cell are
computed for different APC-dependent β-catenin degradation rates (k3). The dashed line indicates the maximum possible β-catenin concentration,
which is determined by the synthesis rate (v1) and APC-independent degradation rate constant (k2). c: Extracellular Dkk concentration at the
location of the mutant cell (cell 11) is computed for different APC-dependent β-catenin degradation rates (k3). All other parameters, including the
diffusion coefficient D, are set to the reference parameter values (Additional file 1: Table S1) in the simulations
In summary, we showed that a mutant cell affects the
target gene mRNA expression along the porto-central
axis. The strength of the paracrine effect of the mutant
cell on wild-type cells can be modulated by changing
the mutation strength or the diffusion coefficient of Dkk.
While small diffusion coefficients result in a rather local
impact in the immediate neighbourhood of the mutant
cell, larger diffusion coefficients reduce the local impact
by distributing it across longer distances. While stronger
mutations induce a stronger downregulation of target
gene mRNA expression, we found the maximum possible
impact to be limited. The position of the mutant along the
porto-central axis has only minor impact on our results.
Quantification of Dkk distributed by a mutant cell
So far, our analyses of the mutant scenario revealed that
the mutant cell affects the target gene mRNA expres-
sion in wild-type cells but that this impact is limited and
restricted to the cells in the vicinity of the mutant cell
(Figs. 5 and 8). We wonder whether this restriction of the
paracrine effect is due to the specific parametrisation of
a b
Fig. 8 Effect of the diffusion coefficient on target gene mRNA expression. a: The value of the diffusion coefficient is varied over several orders of
magnitude and the relative change of target gene mRNA expression in the readout cell is calculated. b: The influence of the diffusion coefficient on
magnitude and spatial range of target gene expression is exemplarily shown for different diffusion coefficients, as indicated in (a): (i) D =0.15 μm2s ,
(ii) D =1 μm2s , (iii) D =10 μm
2
s (reference parameter set), (iv) D =500 μm
2
s
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our model or whether this is a more general property. To
address this question, we analysed the maximum impact
of paracrine regulation in our model. The impact is
strongly dependent on the amount of Dkk mediating the
paracrine regulation, that is, Dkk which originates from
themutant cell and reaches the adjacent wild-type hepato-
cytes; hereafter referred to as Dkk*. To our knowledge, it is
experimentally very difficult to measure extracellular Dkk
directly in vivo or in situ. We thus aimed to derive a math-
ematical expression to estimate the maximum amount of
Dkk* that depends on experimentally accessible quanti-
ties. Our previous analysis (Fig. 7c) showed that Dkk of the
mutant cell is maximised in the case of maximum muta-
tion strength (k3 = 0). Using this assumption of maxi-
mummutation strength, we derive an analytic equation to
quantify Dkk* (Additional file 1, Section C). The equation
reveals that Dkk* reaching a particular wild-type cell can
be calculated from the difference of Dkk mRNA under
wild-type and mutant condition at the location of the
mutant cell. The feasibility of spatially resolved quantifi-
cation of mRNA in liver has recently been shown [97].
Furthermore, Dkk* depends on the ratio of Dkk transla-
tion and degradation rates (k12/k13), which can also be
experimentally determined [80]. Finally, Dkk* depends on
a proportion factor (kp), which quantifies the maximum
fraction of mutant-derived Dkk reaching wild-type hep-
atocytes. For any wild-type cell, we computed an upper
bound for this proportion factor that only depends on the
cell’s distance from the mutant cell and is independent
of other model parameters (Table 1). Hence, all processes
that determine the maximum possible paracrine regula-
tion can either be measured in experiments or be theoret-
ically estimated in a parameter-independent manner.
Although this analysis does not allow for direct conclu-
sions on the maximum possible effect of a mutant cell
on the gene expression in surrounding wild-type cells it
demonstrates that only a small fraction of Dkk produced
by the mutant cell acts via paracrine regulation on the
surrounding wild-type hepatocytes.
Table 1 Proportion of mutant cell-produced Dkk reaching a
wild-type cell. A parameter-independent upper bound for the
proportion of mutant cell (cell 11) produced Dkk reaching a
wild-type cell is computed depending on the distance between
both cells (derived in Additional file 1, section C)







The hepatocytes that adjoin liver sinusoids constitute an
example in which spatial organisation is of critical impor-
tance for gene expression and cell function, and conse-
quently for the adequate performance of the liver in the
mammalian body. Factors generating the functional zona-
tion of the liver sinusoids are concentration gradients of
extracellular factors, such as oxygen, hormones and mor-
phogens as well as intracellular components of theWnt/β-
catenin signalling pathway [6–12]. Our study investigated
the autocrine and paracrine influence of Dkk, an inhibitor
of Wnt/β-catenin signalling that is secreted by hepato-
cytes [25, 26, 28–34]. We investigated the impact of Dkk
on the spatial expression profiles of hepatic target genes in
the presence of an APC gradient and Wnt stimulus under
wild-type and mutant conditions.
The results of our study can be summarised into two
main points. First, the autocrine regulation by the Dkk
feedback generally reduces target gene mRNA expression
in wild-type hepatocytes as well as the steepness of the tar-
get gene mRNA expression profile along the porto-central
axis in comparison to the simulation without Dkk feed-
back. This influence can be counteracted by Dkk diffusion
because diffusion distributes and dilutes Dkk within the
sinusoid. Second, a single cell harbouring a mutation that
impedes APC-dependent β-catenin degradation amidst
20 wild-type hepatocytes already causes a considerable
increase in the average extracellular Dkk concentration in
the space of Disse. However, our simulations demonstrate
that the paracrine influence of this mutation induced Dkk
concentration has only limited impact on the wild-type
hepatocytes, and only in the immediate vicinity of the
mutant cell.
Our analysis shows that the impact of mutant cell
derived Dkk on wild-type neighbours is limited on mul-
tiple levels. First, the model predicts an upper limit in
the Dkk concentration that the mutant cell can produce
due to the mutation that impedes the APC-dependent
β-catenin degradation. This maximum is a consequence
of the maximum possible β-catenin concentration, which
is reached if APC-dependent degradation of β-catenin is
completely lost. Second, the diffusion process in com-
bination with Dkk clearance limits the amount of Dkk
that eventually reaches the neighbouring wild-type hep-
atocytes. We quantified how much of the Dkk produced
by the mutant cell actually reaches wild-type cells in
the immediate neighbourhood by means of a propor-
tion factor and calculated an upper bound. This pro-
portion factor decreases with increasing distance of the
wild-type hepatocyte from the mutant cell, illustrating
the spatial limitation of the paracrine Dkk impact to
the immediate vicinity of the mutant cell. Third, the
autocrine Dkk feedback regulation of the hepatocytes
reduces the impact of mutant cell derived Dkk on target
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gene mRNA expression. Dkk produced by a wild-type
hepatocyte can suffice to saturate the cell’s LRP recep-
tors. In this way, it counteracts the paracrine influence of
the Dkk that is produced by the mutant cell. Finally, the
signalling events of the wild-type hepatocytes limit the
possible impact of LRP-bound Dkk by restricting concen-
trations of signalmediators such as LRP receptor, Dsh, and
β-catenin.
Our model predicts an impact of Dkk on hepatic tar-
get gene expression in the vicinity of a mutant cell. This
prediction of local impact is distinct from the results of
the published Dkk diffusion model in hair follicle devel-
opment [33] or in the colon [34]. These models adapt
modified Turing models [98]. There, a pathway activator
and inhibitor are produced by each cell and both diffuse
and affect surrounding cells. This mechanism allows for
far-ranging pattern formation [99]. Such patterns do not
occur if only a negative feedback regulator is considered
such as Dkk in our model. Since experimental obser-
vations suggest that hepatocytes do not produce Wnt
[9, 86] we did not consider a positive Wnt-mediated feed-
back mechanism in our approach.
While we have shown that the paracrine influence of
mutant cell produced Dkk is limited in magnitude and
space, its impact can still be augmented in our model. An
obvious approach is to assume several mutant cells since
they collectively producemore Dkk than themaximal Dkk
concentration that can be produced by a single mutant
cell. Simulations show that additional mutant cells indeed
augment the impact of a single cell (Additional file 1:
Figure S2). A further possibility to increase the impact of
mutant-derived Dkk is that the mutation might allow for a
more efficient translation of Dkk mRNA in contrast to the
surrounding wild-type cells. Under this specific assump-
tion, the change of target gene mRNA expression in the
wild-type hepatocytes could be reduced to about 50% in
our model (Additional file 1: Figure S3).
It is also conceivable that larger quantities of Dkk
originate from more distant sources and reach the sinu-
soid through the blood stream and affect Wnt/β-catenin
dependent target gene expression in hepatocytes. For a
detailed analysis of such a scenario, an extension of our
model would be necessary that takes into account pro-
cesses of convection via the blood stream, transition of
Dkk from blood vessels into the space of Disse as well as
multi-dimensional diffusion of Dkk in that space. Such an
extended model could also be used to investigate whether
a local increase of Dkk in the space of Disse caused by
mutant hepatocytes results in higher concentrations of
Dkk in the blood.
The compelling number of published mathematical
models addressing Wnt/β-catenin signalling [45–47] pro-
cesses demonstrates the strong demand to mechanisti-
cally understand the regulation of this pathway. To our
knowledge, our model is the first that combines Wnt/β-
catenin signalling events and target gene expression with
their regulation by feedback mechanisms and diffusion
of pathway inhibitors and embeds all these processes
into the particular context of liver-specific concentration
gradients and mutations. This mechanistic detail of our
model was essential to identify the particular processes
at the multiple levels of hepatic β-catenin-regulated tar-
get gene expression that limit the paracrine impact of
Dkk. As all models, our model is a simplification of the
complex underlying biological processes. Many elemen-
tary reactions of signalling molecules have been lumped
into condensed mathematical expressions of regulatory
dependencies. In consequence, sequestration of signalling
components into intermediate complexes are not explic-
itly represented. The approach is however very common
and proved very useful in ODE modelling [81–83]. In
the future, our model can be used as a basis to anal-
yse the interplay of additional extra-cellular modulators of
Wnt/β-catenin signalling [25, 26] and their impact on the
zonation of hepatic target gene expression.
Conclusions
We present the first detailed mathematical model that
describes the autocrine and paracrine regulation of hep-
atic Wnt/β-catenin target gene expression by the secreted
pathway inhibitor Dkk in a line of wild-type hepatocytes,
and in the presence of cells that harbour amutation result-
ing in aberrant intracellular signal transduction. Our sim-
ulations demonstrate that the presence of a single mutant
cell already considerably increases Dkk levels in the space
of Disse. However, the impact of these elevated Dkk levels
on wild-type hepatocytes is confined in space and mag-
nitude. The concerted action of autocrine and paracrine
regulation by Dkk and Wnt/β-catenin signal transduc-
tion allows wild-type hepatocytes to largely maintain their
gene expression in the presence of a mutant cell.
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